StockNews.com began coverage on shares of SenesTech (NASDAQ:SNES – Free Report) in a research report released on Monday. The brokerage issued a sell rating on the stock.
SenesTech Price Performance
Shares of SNES opened at $2.58 on Monday. The business’s fifty day simple moving average is $3.51 and its two-hundred day simple moving average is $5.67. The company has a current ratio of 4.68, a quick ratio of 3.49 and a debt-to-equity ratio of 0.05. SenesTech has a 12 month low of $1.90 and a 12 month high of $55.26.
SenesTech (NASDAQ:SNES – Get Free Report) last issued its earnings results on Thursday, August 8th. The company reported ($3.08) EPS for the quarter, beating the consensus estimate of ($3.20) by $0.12. The business had revenue of $0.46 million for the quarter, compared to the consensus estimate of $0.49 million. SenesTech had a negative return on equity of 168.64% and a negative net margin of 464.09%. During the same period last year, the business posted ($84.03) EPS. On average, equities analysts expect that SenesTech will post -11 earnings per share for the current year.
SenesTech Company Profile
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Further Reading
- Five stocks we like better than SenesTech
- What is the Dow Jones Industrial Average (DJIA)?
- TJX Stock: A Buying Opportunity Before the Holiday Rush
- Airline Stocks – Top Airline Stocks to Buy Now
- Micron’s Blowout Results Pave the Way for Seagate’s Stock Surge
- Ride Out The Recession With These Dividend Kings
- Zeta Global’s AI Cloud: Your Secret Weapon for Massive Growth
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.
